|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMSP0505AI07
|
type III H antigen(d18:1/24:1(15Z))
|
Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
|
Hex(4)-HexNAc(2)-Fuc(2)-Cer 42:2;O2
|
C94H167N3O41
|
1994.107512
|
|
LMSP0505AI08
|
type III H antigen(d18:1/26:1(17Z))
|
Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
|
Hex(4)-HexNAc(2)-Fuc(2)-Cer 44:2;O2
|
C96H171N3O41
|
2022.138812
|
|
LMSP0505AJ01
|
type III A antigen(d18:1/16:0)
|
GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
|
Hex(4)-HexNAc(3)-Fuc(2)-Cer 34:1;O2
|
C94H166N4O46
|
2087.077336
|
|
LMSP0505AJ02
|
type III A antigen(d18:1/18:0)
|
GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
|
Hex(4)-HexNAc(3)-Fuc(2)-Cer 36:1;O2
|
C96H170N4O46
|
2115.108636
|
|
LMSP0505AJ03
|
type III A antigen(d18:1/20:0)
|
GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
Hex(4)-HexNAc(3)-Fuc(2)-Cer 38:1;O2
|
C98H174N4O46
|
2143.139936
|
|
LMSP0505AJ04
|
type III A antigen(d18:1/22:0)
|
GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(4)-HexNAc(3)-Fuc(2)-Cer 40:1;O2
|
C100H178N4O46
|
2171.171236
|
|
LMSP0505AJ05
|
type III A antigen(d18:1/24:0)
|
GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
|
Hex(4)-HexNAc(3)-Fuc(2)-Cer 42:1;O2
|
C102H182N4O46
|
2199.202536
|
|
LMSP0505AJ06
|
type III A antigen(d18:1/26:0)
|
GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
|
Hex(4)-HexNAc(3)-Fuc(2)-Cer 44:1;O2
|
C104H186N4O46
|
2227.233836
|
|
LMSP0505AJ07
|
type III A antigen(d18:1/24:1(15Z))
|
GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
|
Hex(4)-HexNAc(3)-Fuc(2)-Cer 42:2;O2
|
C102H180N4O46
|
2197.186886
|
|
LMSP0505AJ08
|
type III A antigen(d18:1/26:1(17Z))
|
GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
|
Hex(4)-HexNAc(3)-Fuc(2)-Cer 44:2;O2
|
C104H184N4O46
|
2225.218186
|
|
LMSP0505AK01
|
nLc5Cer(d18:1/16:0)
|
GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
|
Hex(3)-HexNAc(2)-Cer 34:1;O2
|
C68H123N3O28
|
1429.829317
|
|
LMSP0505AK02
|
nLc5Cer(d18:1/18:0)
|
GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
|
Hex(3)-HexNAc(2)-Cer 36:1;O2
|
C70H127N3O28
|
1457.860617
|
|
LMSP0505AK03
|
nLc5Cer(d18:1/20:0)
|
GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
Hex(3)-HexNAc(2)-Cer 38:1;O2
|
C72H131N3O28
|
1485.891917
|
|
LMSP0505AK04
|
nLc5Cer(d18:1/22:0)
|
GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(3)-HexNAc(2)-Cer 40:1;O2
|
C74H135N3O28
|
1513.923217
|
|
LMSP0505AK05
|
nLc5Cer(d18:1/24:0)
|
GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
|
Hex(3)-HexNAc(2)-Cer 42:1;O2
|
C76H139N3O28
|
1541.954517
|
|
LMSP0505AK06
|
nLc5Cer(d18:1/26:0)
|
GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
|
Hex(3)-HexNAc(2)-Cer 44:1;O2
|
C78H143N3O28
|
1569.985817
|
|
LMSP0505AK07
|
nLc5Cer(d18:1/24:1(15Z))
|
GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
|
Hex(3)-HexNAc(2)-Cer 42:2;O2
|
C76H137N3O28
|
1539.938867
|
|
LMSP0505AK08
|
nLc5Cer(d18:1/26:1(17Z))
|
GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
|
Hex(3)-HexNAc(2)-Cer 44:2;O2
|
C78H141N3O28
|
1567.970167
|
|
LMSP0505AL01
|
nLc6Cer(d18:1/16:0)
|
Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
|
Hex(4)-HexNAc(2)-Cer 34:1;O2
|
C74H133N3O33
|
1591.882142
|
|
LMSP0505AL02
|
nLc6Cer(d18:1/18:0)
|
Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
|
Hex(4)-HexNAc(2)-Cer 36:1;O2
|
C76H137N3O33
|
1619.913442
|
|
LMSP0505AL03
|
nLc6Cer(d18:1/20:0)
|
Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
Hex(4)-HexNAc(2)-Cer 38:1;O2
|
C78H141N3O33
|
1647.944742
|
|
LMSP0505AL04
|
nLc6Cer(d18:1/22:0)
|
Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(4)-HexNAc(2)-Cer 40:1;O2
|
C80H145N3O33
|
1675.976042
|
|
LMSP0505AL05
|
nLc6Cer(d18:1/24:0)
|
Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
|
Hex(4)-HexNAc(2)-Cer 42:1;O2
|
C82H149N3O33
|
1704.007342
|
|
LMSP0505AL06
|
nLc6Cer(d18:1/26:0)
|
Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
|
Hex(4)-HexNAc(2)-Cer 44:1;O2
|
C84H153N3O33
|
1732.038642
|
|
LMSP0505AL07
|
nLc6Cer(d18:1/24:1(15Z))
|
Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
|
Hex(4)-HexNAc(2)-Cer 42:2;O2
|
C82H147N3O33
|
1701.991692
|
|
LMSP0505AL08
|
nLc6Cer(d18:1/26:1(17Z))
|
Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
|
Hex(4)-HexNAc(2)-Cer 44:2;O2
|
C84H151N3O33
|
1730.022992
|
|
LMSP0505AM01
|
type II H antigen(d18:1/16:0)
|
Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
|
Hex(4)-HexNAc(2)-Fuc-Cer 34:1;O2
|
C80H143N3O37
|
1737.940052
|
|
LMSP0505AM02
|
type II H antigen(d18:1/18:0)
|
Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
|
Hex(4)-HexNAc(2)-Fuc-Cer 36:1;O2
|
C82H147N3O37
|
1765.971352
|
|
LMSP0505AM03
|
type II H antigen(d18:1/20:0)
|
Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
Hex(4)-HexNAc(2)-Fuc-Cer 38:1;O2
|
C84H151N3O37
|
1794.002652
|
|
LMSP0505AM04
|
type II H antigen(d18:1/22:0)
|
Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(4)-HexNAc(2)-Fuc-Cer 40:1;O2
|
C86H155N3O37
|
1822.033952
|
|
LMSP0505AM05
|
type II H antigen(d18:1/24:0)
|
Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
|
Hex(4)-HexNAc(2)-Fuc-Cer 42:1;O2
|
C88H159N3O37
|
1850.065252
|
|
LMSP0505AM06
|
type II H antigen(d18:1/26:0)
|
Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
|
Hex(4)-HexNAc(2)-Fuc-Cer 44:1;O2
|
C90H163N3O37
|
1878.096552
|
|
LMSP0505AM07
|
type II H antigen(d18:1/24:1(15Z))
|
Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
|
Hex(4)-HexNAc(2)-Fuc-Cer 42:2;O2
|
C88H157N3O37
|
1848.049602
|
|
LMSP0505AM08
|
type II H antigen(d18:1/26:1(17Z))
|
Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
|
Hex(4)-HexNAc(2)-Fuc-Cer 44:2;O2
|
C90H161N3O37
|
1876.080902
|
|
LMSP0505AN01
|
|
Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
|
Hex(4)-HexNAc(3)-Cer 34:1;O2
|
C82H146N4O38
|
1794.961516
|
|
LMSP0505AN02
|
|
Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
|
Hex(4)-HexNAc(3)-Cer 36:1;O2
|
C84H150N4O38
|
1822.992816
|
|
LMSP0505AN03
|
|
Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
Hex(4)-HexNAc(3)-Cer 38:1;O2
|
C86H154N4O38
|
1851.024116
|
|
LMSP0505AN04
|
|
Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(4)-HexNAc(3)-Cer 40:1;O2
|
C88H158N4O38
|
1879.055416
|
|
LMSP0505AN05
|
|
Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
|
Hex(4)-HexNAc(3)-Cer 42:1;O2
|
C90H162N4O38
|
1907.086716
|
|
LMSP0505AN06
|
|
Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
|
Hex(4)-HexNAc(3)-Cer 44:1;O2
|
C92H166N4O38
|
1935.118016
|
|
LMSP0505AN07
|
|
Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
|
Hex(4)-HexNAc(3)-Cer 42:2;O2
|
C90H160N4O38
|
1905.071066
|
|
LMSP0505AN08
|
|
Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
|
Hex(4)-HexNAc(3)-Cer 44:2;O2
|
C92H164N4O38
|
1933.102366
|
|
LMSP0505AO01
|
type II B antigen(d18:1/16:0)
|
Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
|
Hex(5)-HexNAc(2)-Fuc-Cer 34:1;O2
|
C86H153N3O42
|
1899.992877
|
|
LMSP0505AO02
|
type II B antigen(d18:1/18:0)
|
Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
|
Hex(5)-HexNAc(2)-Fuc-Cer 36:1;O2
|
C88H157N3O42
|
1928.024177
|
|
LMSP0505AO03
|
type II B antigen(d18:1/20:0)
|
Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
Hex(5)-HexNAc(2)-Fuc-Cer 38:1;O2
|
C90H161N3O42
|
1956.055477
|
|
LMSP0505AO04
|
type II B antigen(d18:1/22:0)
|
Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
Hex(5)-HexNAc(2)-Fuc-Cer 40:1;O2
|
C92H165N3O42
|
1984.086777
|
|
LMSP0505AO05
|
type II B antigen(d18:1/24:0)
|
Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
|
Hex(5)-HexNAc(2)-Fuc-Cer 42:1;O2
|
C94H169N3O42
|
2012.118077
|
|
LMSP0505AO06
|
type II B antigen(d18:1/26:0)
|
Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
|
Hex(5)-HexNAc(2)-Fuc-Cer 44:1;O2
|
C96H173N3O42
|
2040.149377
|
|
LMSP0505AO07
|
type II B antigen(d18:1/24:1(15Z))
|
Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
|
Hex(5)-HexNAc(2)-Fuc-Cer 42:2;O2
|
C94H167N3O42
|
2010.102427
|
|
LMSP0505AO08
|
type II B antigen(d18:1/26:1(17Z))
|
Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
|
Hex(5)-HexNAc(2)-Fuc-Cer 44:2;O2
|
C96H171N3O42
|
2038.133727
|